Ausralia's Clever Culture Systems hits 17-week high after sales agreement with Astrazeneca
05/12/2024 24:56
** Shares of technology company Clever Culture Systems
CC5.AX rise as much as 47.1% to A$0.025, their highest level
since Aug 7
** Co received a purchase order from Britain's Astrazeneca
AZN.L to deliver 4 additional APAS Independence instruments
bringing total Astrazeneca commitments to 9 instruments, valued
at about A$7.2 million ($4.63 million),
** 8,986,281 shares change hands, compared with the 30-day
average volume of 1,094,973
** Stock has risen 54.6% this year as of last close
($1 = 1.5564 Australian dollars)
(Reporting By Nichiket Sunil)
((Nichiket.Sunil@thomsonreuters.com))
Recent news on Clever Culture Systems
See all newsBrief: Clever Culture Systems Says Novo Nordisk Expand Use Of Apas Independence
Australia's Clever Culture Systems jumps nearly 29% on Novo Nordisk order
Australia's Clever Culture Systems falls after swinging to annual loss
Brief: Clever Culture Systems Says No Dividend Proposed For FY2026
Brief: Clever Culture Systems Ltd Says CSL Orders APAS Independence For Global QC Operations